Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients

Characteristics of the transformation of primary to secondary calciprotein particles (CPPs) in serum, including the size of secondary CPP (CPP2) aggregates and the time of transformation (T50), may be markers for arterial calcification in patients undergoing hemodialysis (HD). We examined the associ...

Full description

Saved in:
Bibliographic Details
Published in:American journal of kidney diseases Vol. 77; no. 3; pp. 346 - 354
Main Authors: Chen, Wei, Fitzpatrick, Jessica, Monroy-Trujillo, Jose M., Sozio, Stephen M., Jaar, Bernard G., Estrella, Michelle M., Serrano, Jishyra, Anokhina, Viktoriya, Miller, Benjamin L., Melamed, Michal L., Bushinsky, David A., Parekh, Rulan S.
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-03-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Characteristics of the transformation of primary to secondary calciprotein particles (CPPs) in serum, including the size of secondary CPP (CPP2) aggregates and the time of transformation (T50), may be markers for arterial calcification in patients undergoing hemodialysis (HD). We examined the associations of CPP2 aggregate size and T50 with arterial calcification in incident HD patients. Prospective cohort study. Incident HD patients (n=402with available CPP2 measures and n=388with available T50 measures) from the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) Study Serum CPP2 size and T50 at baseline. Primary outcomes were baseline coronary artery and thoracic aorta calcifications. Exploratory outcomes included baseline arterial stiffness, measured by pulse wave velocity (PWV) and ankle brachial index, and longitudinally, repeat measures of PWV and all-cause mortality. Tobit regression, multiple linear regression, Poisson regression, linear mixed-effects regression, and Cox proportional hazards regression. Mean age was 55±13 years, 41% were women, 71% were Black, and 57% had diabetes mellitus. Baseline CPP2 size and T50 were correlated with baseline fetuin A level (r=−0.59 for CPP2 and 0.44 for T50; P<0.001 for both), but neither was associated with baseline measures of arterial calcification or arterial stiffness. Baseline CPP2 size and T50 were not associated with repeat measures of PWV. During a median follow-up of 3.5 (IQR, 1.7-6.2) years, larger CPP2 was associated with higher risk for mortality (HR, 1.17 [95% CI, 1.05-1.31] per 100nm larger CPP2 size) after adjusting for demographics and comorbid conditions, but there was no association between baseline T50 and risk for mortality. Possible imprecision in assays, small sample size, limited generalizability to incident HD populations with different racial composition, and residual confounding. In incident HD patients, neither CPP2 size nor T50 was associated with prevalent arterial calcification and stiffness. Larger CPP2 was associated with risk for mortality, but this finding needs to be confirmed in future studies.
Bibliography:Authors’ Contributions: Research idea and study design: WC, JF, DAB, RSP; data acquisition: JF, JMM-T, SMS, BGJ, MME, JS, VA, BLM; data processing/analysis/interpretation: WC, JF, MLM, DAB, RSP; statistical analysis: WC, JF, RSP; mentorship: DAB, RSP. Each author contributed important intellectual content during manuscript drafting or revision and agrees to be personally accountable for the individual’s own contributions and to ensure that questions pertaining to the accuracy or integrity of any portion of the work, even one in which the author was not directly involved, are appropriately investigated and resolved, including with documentation in the literature if appropriate.
ISSN:0272-6386
1523-6838
DOI:10.1053/j.ajkd.2020.05.031